Baird initiated coverage of bluebird bio with an outperform rating and $10 price target, which implies 104% upside from Monday's close.
from International: Top News And Analysis https://ift.tt/63uaWov
via IFTTT
Tuesday, March 7, 2023
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment